SeaStar Medical Holding Corporation Common Stock (ICU) Stock Price
ICUStock
$3.18−60.13%52W
Market Cap$14.01M
P/E—
PEG Ratio—
Div yield—
Beta-1.03
ICU Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)18.96%
Price vs S&P 500 (4W)-10.32%
VGM Score57.32
ICU Earnings Surprise History
Q2 25-1.80est. -4.30
Q3 25-1.30est. -1.50
Q4 25-0.80est. -1.01
Q1 26-0.90est. -0.82
Q2 26-0.91est. -0.97
ICU Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ICUSeaStar Medical Holding Corporation Common Stock | D | A | C | $3.18 |
| SYKStryker Corporation | C | B | C | $330.59 |
| MMM3M Company | C | D | B | $179.37 |
| BSXBoston Scientific Corp. | C | B | D | $49.86 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.78 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.64 |
| RMDResMed Inc. | C | B | C | $236.59 |
| DXCMDexCom, Inc. | D | B | B | $89.16 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $348.48 |
| SOLVSolventum Corporation | C | C | B | $91.61 |
| BAXBaxter International Inc. | B | D | B | $26.29 |
About SeaStar Medical Holding Corporation Common Stock
SeaStar Medical develops extracorporeal therapies designed to reduce hyperinflammation and its damaging effects on vital organs. The company's proprietary platform targets the inflammatory cells and cytokines that drive systemic immune responses and tissue damage. It operates a single Device segment focused on commercializing these therapeutic solutions.